A systematic review on the frequency of BRCA promoter methylation in breast and ovarian carcinomas of BRCA germline mutation carriers: Mutually exclusive, or not?
Authors:
- 1 July 2018
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 127, 29-41
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Integrated analysis of genome-wide DNA methylation and gene expression profiles in molecular subtypes of breast cancerNucleic Acids Research, 2013
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Association of BRCA1 and BRCA2 Mutations With Survival, Chemotherapy Sensitivity, and Gene Mutator Phenotype in Patients With Ovarian CancerJAMA, 2011
- Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cellsProceedings of the National Academy of Sciences, 2011
- Assays for Hypermethylation of the BRCA1 Gene Promoter in Tumor Cells to Predict Sensitivity to PARP-Inhibitor Therapy2011
- Integrated genomic analyses of ovarian carcinomaNature, 2011
- Methylation is less abundant in BRCA1-associated compared with sporadic breast cancerAnnals of Oncology, 2008
- Variation of Breast Cancer Risk Among BRCA1/2 CarriersJAMA, 2008
- Hallmarks of 'BRCAness' in sporadic cancersNature Reviews Cancer, 2004
- Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 StudiesThe American Journal of Human Genetics, 2003